Corvus Pharmaceuticals Inc (CRVS)

Other Income/Expenses (Net)

$3.54M

TTM · Period ending: · USD

CRVS logo

CRVS Other Income/Expenses (Net)

Latest reported$3.54M
CRVS TTM Other Income/Expenses (Net) (-$17.57M → $3.54M)
High-resolution chart · PNG

CRVS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Corvus Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
3,543,000
3,758,000
27,688,000
23,784,000
-9,593,000
-10,182,000
-34,745,000
-31,739,000
783,000
-1,771,000
-3,622,000
-6,770,000
-8,688,000
-9,157,000
-8,742,000
-7,018,000
-6,286,000
-5,398,000
-4,611,000
35,041,000
36,716,000
37,334,000
37,765,000
932,000
1,392,000
1,854,000
2,182,000
2,451,000
2,593,000
2,602,000
2,283,000
1,881,000
1,457,000
1,023,000
861,000
765,000
717,000
704,000
602,000
503,000
293,000
-17,787,000
-17,565,000
-17,630,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.